NEET II: J&K govt will help conduct the exam in Srinagar, says CBSE

Published On 2016-07-23 10:26 GMT   |   Update On 2016-07-23 10:26 GMT

CBSE on July 21 said the Jammu and Kashmir government has agreed to provide all necessary support for conducting the NEET-II examination on July 24 in Srinagar, where curfew has been imposed in the wake of violence following killing of a militant leader.


The admit cards issued by CBSE will be considered as curfew passes as agreed by the state government, it said in a statement here.


CBSE said that for candidates whose old centre was Delhi Public School, Athwajan, the new centre would be either Sri Pratap College or Amar Singh College.


About 600 students from Roll Nos. 82500541 to 82501140 can take the exam in Sri Pratap college while another 600 students from Roll Nos. 82501141 to 82501740 can take the exam at Amar Singh College.


For candidates who had Delhi Public School, Humhama Sheikhpura, their centre, there is no change. About 540 students from Roll Nos. 82500001 to 82500540 can take the exam at this centre.


CBSE said candidates are required to make necessary arrangements so that they may be able to reach their centres on time on July 24 for the National Eligibility cum Entrance Test (NEET II) exam for entrance to medical and dental colleges.


The last reporting time at the centres is 09.30 am, the statement said.


The printed copy of the admit card will be made available to the candidates from July 23 at their new allotted centres in Srinagar. Also, arrangement of photographer is being made to take their postcard and passport size photographs which is a mandatory condition for this examination, the statement said.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News